Literature DB >> 29193781

Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.

Hannah Mary Thomas1,2, Paul E Kinahan3, James Jebaseelan E Samuel2, Stephen R Bowen1,3.   

Abstract

INTRODUCTION: To quantitatively estimate the impact of different methods for both boost volume delineation and respiratory motion compensation of [18F] FDG PET/CT images on the fidelity of planned non-uniform 'dose painting' plans to the prescribed boost dose distribution.
METHODS: Six locally advanced non-small cell lung cancer (NSCLC) patients were retrospectively reviewed. To assess the impact of respiratory motion, time-averaged (3D AVG), respiratory phase-gated (4D GATED) and motion-encompassing (4D MIP) PET images were used. The boost volumes were defined using manual contour (MANUAL), fixed threshold (FIXED) and gradient search algorithm (GRADIENT). The dose painting prescription of 60 Gy base dose to the planning target volume and an integral dose of 14 Gy (total 74 Gy) was discretized into seven treatment planning substructures and linearly redistributed according to the relative SUV at every voxel in the boost volume. Fifty-four dose painting plan combinations were generated and conformity was evaluated using quality index VQ0.95-1.05, which represents the sum of planned dose voxels within 5% deviation from the prescribed dose. Trends in plan quality and magnitude of achievable dose escalation were recorded.
RESULTS: Different segmentation techniques produced statistically significant variations in maximum planned dose (P < 0.02), as well as plan quality between segmentation methods for 4D GATED and 4D MIP PET images (P < 0.05). No statistically significant differences in plan quality and maximum dose were observed between motion-compensated PET-based plans (P > 0.75). Low variability in plan quality was observed for FIXED threshold plans, while MANUAL and GRADIENT plans achieved higher dose with lower plan quality indices.
CONCLUSIONS: The dose painting plans were more sensitive to segmentation of boost volumes than PET motion compensation in this study sample. Careful consideration of boost target delineation and motion compensation strategies should guide the design of NSCLC dose painting trials.
© 2017 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  zzm321990NSCLCzzm321990; PET/CT; dose painting; respiratory gating; segmentation

Mesh:

Substances:

Year:  2017        PMID: 29193781      PMCID: PMC5810941          DOI: 10.1111/1754-9485.12693

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  28 in total

Review 1.  A review on segmentation of positron emission tomography images.

Authors:  Brent Foster; Ulas Bagci; Awais Mansoor; Ziyue Xu; Daniel J Mollura
Journal:  Comput Biol Med       Date:  2014-04-28       Impact factor: 4.589

2.  Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

Authors:  C A Perez; T F Pajak; P Rubin; J R Simpson; M Mohiuddin; L W Brady; R Perez-Tamayo; M Rotman
Journal:  Cancer       Date:  1987-06-01       Impact factor: 6.860

3.  A comparison between amplitude sorting and phase-angle sorting using external respiratory measurement for 4D CT.

Authors:  Wei Lu; Parag J Parikh; James P Hubenschmidt; Jeffrey D Bradley; Daniel A Low
Journal:  Med Phys       Date:  2006-08       Impact factor: 4.071

4.  Feasibility and sensitivity study of helical tomotherapy for dose painting plans.

Authors:  Michael A Deveau; Stephen R Bowen; David C Westerly; Robert Jeraj
Journal:  Acta Oncol       Date:  2010-10       Impact factor: 4.089

5.  Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.

Authors:  S R Bowen; M J Nyflot; C Herrmann; C M Groh; J Meyer; S D Wollenweber; C W Stearns; P E Kinahan; G A Sandison
Journal:  Phys Med Biol       Date:  2015-04-17       Impact factor: 3.609

6.  The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.

Authors:  Wouter van Elmpt; Dirk De Ruysscher; Anke van der Salm; Annemarie Lakeman; Judith van der Stoep; Daisy Emans; Eugène Damen; Michel Öllers; Jan-Jakob Sonke; José Belderbos
Journal:  Radiother Oncol       Date:  2012-04-06       Impact factor: 6.280

7.  Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation.

Authors:  Hugo J W L Aerts; Johan Bussink; Wim J G Oyen; Wouter van Elmpt; Annemieke M Folgering; Daisy Emans; Marije Velders; Philippe Lambin; Dirk De Ruysscher
Journal:  Lung Cancer       Date:  2011-07-22       Impact factor: 5.705

8.  Four-dimensional positron emission tomography: implications for dose painting of high-uptake regions.

Authors:  Michalis Aristophanous; Jeffrey T Yap; Joseph H Killoran; Aileen B Chen; Ross I Berbeco
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

9.  Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.

Authors:  Mary Feng; Feng-Ming Kong; Milton Gross; Shaneli Fernando; James A Hayman; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

10.  Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.

Authors:  Sana D Karam; Zachary D Horne; Robert L Hong; Don McRae; David Duhamel; Nadim M Nasr
Journal:  Radiat Oncol       Date:  2013-07-10       Impact factor: 3.481

View more
  3 in total

Review 1.  Treatment Intensification in Locally Advanced/Unresectable NSCLC Through Combined Modality Treatment and Precision Dose Escalation.

Authors:  Jing Zeng; Stephen R Bowen
Journal:  Semin Radiat Oncol       Date:  2021-04       Impact factor: 5.934

2.  Positron emission tomography guided dose painting by numbers of lung cancer: Alanine dosimetry in an anthropomorphic phantom.

Authors:  Iosif Papoutsis; Ingerid Skjei Knudtsen; Erlend Peter Skaug Sande; Bernt Louni Rekstad; Michel Öllers; Wouter van Elmpt; Marius Røthe Arnesen; Eirik Malinen
Journal:  Phys Imaging Radiat Oncol       Date:  2022-02-26

3.  4D-CT Attenuation Correction in Respiratory-Gated PET for Hypoxia Imaging: Is It Really Beneficial?

Authors:  Brandon Driscoll; Douglass Vines; Tina Shek; Julia Publicover; Ivan Yeung; Stephen Breen; David Jaffray
Journal:  Tomography       Date:  2020-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.